novo nordisk glp 1 drug launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry GLP-1 Drugs Are Coming, and

This is why weight-loss GLP-1 medications have become so widely discussed in recent years

Furthermore, recent data indicates effectiveness in inhibiting fibrosis advancement, with clinical studies revealing markedly reduced progression rates in individuals treated with semaglutide (5%) compared to placebo groups (19%) (Newsome et al

They often show discounted cash prices that can save you money even if you dont have insurance

However, a shortage in 2022 spurred competition from compounding pharmacies, and arch-rival Eli Lilly 's (LLY +0.76%) Mounjaro and Zepbound (tirzepatide) have come on strong

If you're struggling with access to prescription treatments, talk to a licensed provider about safe, affordable alternatives rather than turning to unproven internet remedies